These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 11769386

  • 1. [Bone complications in diabetic subjects with good metabolic control and without any long-term complications--certain problems. Part III: The influence of hypertension and type 2 diabetes mellitus co-incidence of calcium, phosphorus and magnesium metabolism].
    Zywiec J, Grzeszczak W, Pierzchała K.
    Przegl Lek; 2001; 58(7-8):778-81. PubMed ID: 11769386
    [Abstract] [Full Text] [Related]

  • 2. [Bone complication in diabetic subjects with good metabolic control and without any late complications: selected problems. Part I: calcium, phosphorus and magnesium metabolism].
    Zywiec J, Grzeszczak W, Pierzchała K.
    Przegl Lek; 2001; 58(5):426-30. PubMed ID: 11603176
    [Abstract] [Full Text] [Related]

  • 3. [Bone complication in diabetes subjects with good metabolic control and without longterm complications: certain problems. Part II. Basal parameters of bone turnover].
    Zywiec J, Grzeszczak W, Pierzchała K.
    Przegl Lek; 2001; 58(6):495-7. PubMed ID: 11816739
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Magnesium metabolism in hypertension and type 2 diabetes mellitus.
    Barbagallo M, Dominguez LJ, Resnick LM.
    Am J Ther; 2007; 14(4):375-85. PubMed ID: 17667214
    [Abstract] [Full Text] [Related]

  • 7. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
    Grifò G, Lo Presti R, Montana M, Canino B, Caimi G.
    Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
    [Abstract] [Full Text] [Related]

  • 8. [Selected indicators of calcium-phosphate metabolism in patients with diabetes mellitus].
    Błasiak M, Kuska J, Kokot F, Irzyniec T.
    Endokrynol Pol; 1989 Nov; 40(5):251-62. PubMed ID: 2641514
    [Abstract] [Full Text] [Related]

  • 9. [Phosphorus-calcium metabolism and the secretion of calcium-regulating hormones in diabetic nephropathy].
    Khasanova ER, Mkrtumian AM, Balabolkin MI.
    Ter Arkh; 1994 Nov; 66(10):21-5. PubMed ID: 7863438
    [No Abstract] [Full Text] [Related]

  • 10. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
    Bogdański P, Pupek-Musialik D, Luczak M, Szulińska M.
    Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
    [Abstract] [Full Text] [Related]

  • 11. [Short-term effect of thiazides on magnesium and calcium metabolism and secondarily on that of phosphorus, uric acid, oxalate and cyclic AMP].
    Hodler J, Roulin F, Haldimann B.
    Nephrologie; 1983 Aug; 4(2):60-3. PubMed ID: 6308488
    [Abstract] [Full Text] [Related]

  • 12. Hypomagnesemia in patients with type 2 diabetes.
    Pham PC, Pham PM, Pham SV, Miller JM, Pham PT.
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):366-73. PubMed ID: 17699436
    [Abstract] [Full Text] [Related]

  • 13. Utility of the Dipstick Micraltest II in the screening of microalbuminuria of diabetes mellitus type 2 and essential hypertension.
    Cortés-Sanabria L, Martínez-Ramírez HR, Hernández JL, Rojas-Campos E, Canales-Muñoz JL, Cueto-Manzano AM.
    Rev Invest Clin; 2006 Mar; 58(3):190-7. PubMed ID: 16958293
    [Abstract] [Full Text] [Related]

  • 14. Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus.
    Lal J, Vasudev K, Kela AK, Jain SK.
    J Assoc Physicians India; 2003 Jan; 51():37-42. PubMed ID: 12693452
    [Abstract] [Full Text] [Related]

  • 15. [Changes in calcium and magnesium levels of lymphocytes in patients with diabetes and hypertension].
    Mo Z, Zhang M, Guan Y, Jian W.
    Hunan Yi Ke Da Xue Xue Bao; 1999 Jan; 24(5):471-3. PubMed ID: 12080688
    [Abstract] [Full Text] [Related]

  • 16. Glucose metabolism in patients with essential hypertension.
    García-Puig J, Ruilope LM, Luque M, Fernández J, Ortega R, Dal-Ré R, AVANT Study Group Investigators.
    Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774
    [Abstract] [Full Text] [Related]

  • 17. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure.
    Meloni C, Tatangelo P, Cipriani S, Rossi V, Suraci C, Tozzo C, Rossini B, Cecilia A, Di Franco D, Straccialano E, Casciani CU.
    J Ren Nutr; 2004 Oct; 14(4):208-13. PubMed ID: 15483780
    [Abstract] [Full Text] [Related]

  • 18. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications.
    Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S, Epaminonda P, Masserini B, Beck-Peccoz P, Orsi E, Ambrosi B, Arosio M.
    Diabetes Care; 2007 Jan; 30(1):83-8. PubMed ID: 17192338
    [Abstract] [Full Text] [Related]

  • 19. [Diabetic osteopathy. 4. Laboratory findings].
    Kocián J, Brunová J.
    Vnitr Lek; 1990 May; 36(5):460-6. PubMed ID: 2375077
    [Abstract] [Full Text] [Related]

  • 20. Influence of antihypertensive therapy and blood pressure control on left ventricular geometry and function in subjects with type II diabetes: The Augsburg Diabetes Family Study.
    Kuch B, von Scheidt W, Peter W, Heier M, Wichmann HE, Meisinger C.
    J Hum Hypertens; 2006 Oct; 20(10):757-64. PubMed ID: 16826194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.